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ABSTRACT
Amplex Red (AR) reagent is the most stable and sensitive fluorogenic substrate
known for horseradish peroxidase (HRP). Thus, in the presence of hydrogen
peroxide (H2O2), AR (a nonfluorescent compound) is converted to resorufin (a
strongly fluorescing product) by the action of HRP. In the last years, multiple
assays have been developed using this reagent to quantify a diverse assortment of
analyses and also to detect the activity of many different enzymes. We recently
showed that BzATP, agonist of several ionotropic nucleotide receptors (P2X),
interfered with Amplex Red oxidation catalyzed by HRP. In the present work we
reported that glutamate determinations using Amplex Red Glutamic Acid/Glutamate
Oxidase Assay Kit are also strongly interfered by BzATP. These data are really
interesting because demonstrate that resorufin fluorescence, in the presence of
BzATP, is not proportional to glutamate concentration and, therefore, it must not
be used as method to measure glutamate concentration.
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RESUMEN
Las determinaciones de glutamato utilizando Amplex Red Glutamic Acid
Assay están afectadas por el agonista P2X BzATP
El compuesto Amplex Red (AR) es el sustrato fluorogénico para la peroxidasa
de rábano (HRP) más estable y sensible. Así, en presencia de peróxido de hidróge-
no (H2O2), el AR (un compuesto no fluorescente) es convertido en resorufina (un
producto fuertemente fluorescente) por la acción de la HRP. En los últimos años
se han realizado muchos ensayos utilizando este compuesto para cuantificar un
variado surtido de análisis, así como para detectar la actividad de muchas y va-
riadas enzimas. Recientemente hemos demostrado que el BzATP, un agonista de
varios receptores ionotrópicos de nucleótidos (P2X), interfiere con la oxidación del
Amplex Red catalizada por la HRP. En el presente trabajo mostramos que las de-
terminaciones de glutamato utilizando el kit Amplex Red Glutamic Acid/Glutamate
Oxidase Assay están fuertemente interferidas por el BzATP. Estos datos son real-
mente interesantes porque demuestran que la fluorescencia de la resorufina, en
presencia del BzATP, no es proporcional a la concentración de glutamato y, por
lo tanto, no debe ser utilizada como un método para medir la concentración de
glutamato.
Palabras clave: Amplex Red.—Glutamato.—P2X.—BzATP.—Interferencias.
INTRODUCTION
Amplex Red (AR) reagent is the most stable and sensitive
fluorogenic substrate known for horseradish peroxidase (1). A variety
of novel fluorogenic and chromogenic assays for enzymes that
produce hydrogen peroxide has been developed using this compound.
Thus, these coupled assays permit the ultrasensitive quantitation of
a diverse assortment of analytes, including glucose, galactose,
cholesterol, glutamic acid, xanthine (or hypoxanthine), uric acid,
choline, acetylcholine and hydrogen peroxide, as well as to detect
the activity of many different enzymes (e.g. phospholipase D,
phosphatidylcholine-specific phospholipase C, sphingomyelinase, ...)
(Table 1).
We recently have reported that the precision of such
determinations are affected by the presence in the medium of the
ATP analog, BzATP (2‘-3‘-o-(4-benzoylbenzoyl)-adenosine 5‘-
triphosphate), an agonist of the ionotropic P2 receptors, P2X1, P2X2,
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P2X3 and P2X7 (2, 3). Thus, we showed that AR, in the absence of
H2O2, was quickly oxidized when BzATP was present. Furthermore,
we obtained first evidences that glutamate determinations using
Amplex Red Glutamic Acid/Glutamate Oxidase Assay Kit were also
strongly interfered by BzATP by using individual measurements in a
fluorescence emission spectra (LS55 spectrofluorimeter from Perkin
Elmer). In the present work we showed how this interference can
lead to misinterpret the results and, therefore, to hypothesize effects
that do not correlate with the ones mediated through ionotropic
nucleotide receptors (P2X) in biological systems.
TABLE 1. Examples of Amplex Red-based assays. The limits of detection of the
corresponding metabolites or enzymatic activities are shown
Metabolite Enzymatic
Activity
Amplex Red Catalase Assay Kit 50 mU/ mL
Amplex Red Glutamic Acid/Glutamate Oxidase Assay Kit 1.2 x10–5 U/mL
Amplex Red Glutamic Acid/Glutamate Oxidase Assay Kit
10 nM 40 µU/mL
Amplex Red Glucose/Glucose Oxidase Assay Kit  3 µM 0.05 mU/mL
Amplex Red Galactose/Galactose Oxidase Assay Kit 4 µM 2 mU/mL
Amplex Red Cholesterol Assay Kit 5 ng/mL
Amplex Red Acetylcholine/Acetylcholinesterase Assay Kit
0.3 µM 0.002 U/mL
Amplex Red Uric Acid/Uricase Assay Kit 20 nM 0.2 mU/mL
Amplex Red Xanthine/Xanthine Oxidase Assay Kit 200 nM 0.1 mU/mL
METHODS
Culture of granule cells
All experiments carried out at the Universidad Complutense of
Madrid followed the guidelines of the International Council for
Laboratory Animal Science (ICLAS). Cerebellar cultures were
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prepared following procedures described by León et al. (2006) (4).
Cerebella from three Wistar rat pups (P7) were removed aseptically,
washed once in Earl’s balanced salt solution (EBSS; Gibco BRL),
cut into small pieces and transferred to a screw cap tube. Tissue
fragments were allowed to settle, excess EBSS was aspirated, and
4 mL of EBSS containing 100 U/mL DNAse (Worthington, Lake
Wood NJ), 2.5 mM CaCl2 and 2.5 mM MgCl2 were added. Sixty-five
units of papain (Worthington) were added after it was preactivated
(30 min at 37º C) in 1 mL of EBSS. Air in the tube was displaced
with 95% O2-5% CO2 and the tube was incubated at 37º C for 40
minutes on a shaking platform. Undigested fragments were allowed
to settle and the supernatant was centrifuged at 208 g for 5 min.
The pellet was resuspended in 3 mL of EBSS containing 4.5 mg of
ovomucoid protease inhibitor layered onto an albumin cushion,
which consisted of 3 mL of EBSS containing ovomucoid protease
inhibitor (Worthington) and ovoalbumin (Worthington) at 15 mg/
mL each, and the resuspended pellet was centrifuged at 172 g for
5 min. The resulting pellet was finally resuspended in Neurobasal
medium (Gibco BRL) and the cell number and viability was assessed.
The dissociated cells were plated at a final density of 0.1-0.3 X 106
cells/cm2 on poly-L-lysine-coated glass coverslips or 24-wells plates
(2 cm2 surface area/well) in Neurobasal medium supplemented with
B27 (Gibco, BRL), 100 U/mL penicillin, 0.1 mg/mL streptomycin,
0.25 μg/mL amphotericin B (Sigma), 21 mM KCl and 2 mM
glutamine (Sigma), and were maintained in a humidified incubator
at 37º C in 5 % CO2. After 24 hours Neurobasal medium was replaced
by new fresh medium containing 100 U/mL penicillin, 0.1 mg/mL
streptomycin, 0.25 μg/mL amphotericin B, 21 mM KCl and 0.5 mM
glutamine. The culture medium was replaced every 3 days
afterwards.
Glutamate release experiments
For the glutamate release experiments, cerebellar granule neurons
were plated at a final density of 0.3 X 106 cells/cm2 on 24-wells plates
(2 cm2 surface area/well) pre-coated with 0.1 mg/mL poly-L-lysine
(Biochrom AG, Berlin). 7 to 14 days-old cells were washed twice and
incubate for 1 hour at 37º C with Locke’s solution. 5 minutes before
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to start the experiment, Locke’s solution was changed by a new one
containing 50 μM PDC in order to block the glutamate reuptake
systems. Then, granule neurons were stimulated for 1 min with
BzATP (100 nM-200 µM) in Locke’s solution without Mg2+. All
stimulations were performed in the presence of 3 U/ml of ADA
in order to avoid the presence of adenosine in the medium. Finally,
the medium was aspired and the glutamate content was measured
using the Amplex Red Glutamic Acid Assay Kit (Molecular Probes)
according to the protocol provided by the manufacturer. The
resorfurin fluorescence was detected with a BMG Labtechnologies
96 plate reader using excitation filter at 544 nM and emission filter
at 590 nM.
Analyses of membrane pore formation
To analyze wheter BzATP induced pore formation, cultured
granule cells (14 days old) were exposed for 5 min with BzATP
(without Mg2+) in presence of 2 µM YO-PRO-1, the cell-impermeant
dye, that becomes fluorescent when interacting with DNA. Changes
in fluorescence were continuosly monitored using a fluorescence
microscopy setting excitation wavelength at 490 nm and emission at
510 nm. At the end of each experiment positive control was carried
out making permeable granule cell with 10% triton X-100.
Statistical analysis
Data are presented as mean ± S.E.M. of al least 3 independent
experiments. Comparisons between experimental samples and
controls were carried out using Student’s t-test . Dose-response curve
showing the effect of BzATP on glutamate release were fitted using
GraphPad Prism version 3.00 for Windows, GraphPad Software, San
Diego California.
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RESULTS AND DISCUSSION
Previous works have shown that P2X7 receptor activation, and
also reported for P2X4, P2X2, P2X2/P2X3, can lead to open a large
pore through which glutamate can reach the extracellular medium
(5, 6). Since P2X7 is highly expressed in granule neurons where
distributed, mainly, along neuronal fibers (7) we decided to measure
glutamate content in the extracellular media following P2X7 receptor
activation in order to test whether P2X7 receptor could also open
a pore in these cells. Thus, granule neurons growth in culture for
14 days were stimulated with BzATP for 1 minute and the glutamate
content was measured using the Amplex Red Glutamic Acid Assay
Kit (Molecular Probes) according to the protocol provided by the
manufacturer.
The quantification of glutamate using the Amplex® Red Glutamic
Acid/Glutamic Oxidase Assay Kit provides an ultrasentive method for
detecting glutamic levels as low as 10 nM. We also tried to measure
the glutamate release utilising the enzyme-linked fluorometric assay
based on glutamate dehydrogenase activity and the changes in the
fluorescence of NADPH (8), but the glutamate content in the media
was under the limits of detection by this technique (data not shown).
As it can be observed in Figure 1 the principle of the assay is based
FIGURE 1. Principle of coupled enzymatic assays using Amplex Red reagent.
Oxidation of L-Glutamate by glutamate oxidase results in generation of H2O2,
which is coupled to conversion of the Amplex Red reagent to fluorescent resorufin
by HRP. The detection scheme shown here is used in Amplex® Red Glutamic
Acid/Glutamate Oxidase Assay Kit.
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in the oxidation of L-glutamic acid by glutamate oxidase to produce
α-ketoglutarate, NH3 and H2O2. In a subsequent reaction H2O2 is
reduced by horseradish peroxidase (HRP) using Amplex red reagent
(10-acetyl-3, 7 dihidroxiphenoxazine) as an electron donor which is
transformed to resorufin, a fluorescent compound that has excitation/
emission maxima of ~540/585 nm.
Following the indications of the protocol, a working solution,
containing 50 µM AR, 0.125 U/ml HRP, 0.04 U/ml L-glutamate
oxidase, 0.25 U/ml L-glutamate pyruvate transaminase and 100 µM
L-alanine in 100 mM Tris-HCl, pH 7.5 buffer, was prepared. Next,
several concentrations of L-Glu (100 nM- 4 µM) were added and
incubated at 37º C for 30 min. Finally, resorufin fluorescence was
detected with a BMG Labtechnologies 96 plate reader using excitation
filter at 544 nM and emission filter at 590 nM. As it can be observed
in Figure 2, the resorufin fluorescence was glutamate concentration-
dependent in the range assayed.
FIGURE 2. Detection of L-glutamic acid using the Amplex® Red reagent-based
assay. Each reaction contained 50 μM Amplex® Red reagent, 0.125 U/mL HRP,
0.04 U/mL L-glutamate oxidase, 0.25 U/mL L-glutamate-pyruvate transaminase,
100 μM L-alanine and the indicated amount of L-glutamic acid in 1X reaction
buffer. Reactions were incubated at 37° C. After 30 minutes, resorfurin
fluorescence was detected with a BMG Labtechnologies 96 plate reader using
excitation filter at 544 nM and emission filter at 590 nM.
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Once we knew that resorufin fluorescence was dose-dependent
in the range nano-micromolar of glutamate, we decided to investigate
if extracellular glutamate could increase in response to pore formation
after P2X7 receptor activation. For that purpose, granule neurons
(14 days old) were stimulated for 1 min with several concentrations
of BzATP (100 nM-200 µM), in absence of magnesium, since this ion
has been shown to inhibit P2X7 receptor (2). Next, medium was taken
and the glutamate content was measured using Amplex® Red Glutamic
Acid/Glutamic Oxidase Assay Kit. As it can be observed in Figure 3a,
BzATP induced an increase in resorufin fluorescence that was dose-
dependent. Initially, these data seems to indicate that BzATP induced
pore formation through which glutamate reached extracellular
medium since the profile of glutamate release did not fit to a
saturation kinetic. To verify this hypothesis, granule neurons were
stimulated with BzATP and ATP in presence of YO-PRO-1 as indicated
in methods section. The lack of variations in the YO-PRO-1
fluorescence after granule cell exposure to BzATP (100 µM) or ATP
(100 µM) for 5 minutes discarded the possibility that prolonged
activation of P2X7 could induce pore formation in the plasma
membrane of granule neurons (Figure 3b). Therefore, the non-
saturable profile of the dose-response curve was caused by the
presence of BzATP in the incubation medium and not by a lineal
glutamate release through pore.
In a recent work (9) we showed that BzATP, and other molecules
that contain 4-benzoylbenzoyl groups in their structure, interfere
in the AR oxidation reaction catalyzed by HRP. Thus, BzATP
enhances the AR oxidation mediated by HRP in the absence of
externally added H2O2. This effect is produced by benzophenone
group of BzATP molecule since other ATP agonists did not reproduce
BzATP interferences (9). Therefore, we decided to investigate if
resorufin fluorescence increase observed in Figure 3 could be a
consequence of BzATP interference on Amplex Red oxidation. For
that purpose, a working solution containing 50 µM AR, 0.125 U/ml
HRP, 0.04 U/ml L-glutamate oxidase, 0.25 U/ml L-glutamate pyruvate
transaminase and 100 µM L-alanine was prepared following the
protocol of Amplex® Red Glutamic Acid/Glutamic Oxidase Assay Kit.
This working solution was supplemented with 0.1 µM, 0.5 µM and
1 µM L-Glu respectively and incubated for 30 min at 37º C. Resorufin
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fluorescence showed the following values, showed in Figure 4: Glu
0.1 µM, 909 ± 128 a.u. (n = 3); Glu 0.5 µM, 2713 ± 347 a.u. (n = 3);
Glu 1 µM, 5621 ± 257 a.u. (n = 3). All these values were significantly
enhanced in presence of 10 µM BzATP (Glu 0.1 µM, 1851 ± 304 a.u.,
n = 3, p < 0.01; Glu 0.5 µM 4362 ± 294 a.u., n = 3, p < 0.01; Glu 1
µM, 806551 ± 407 a.u., n = 3, p < 0.01) and 100 µM BzATP (Glu 0.1
µM, 5904 ± 935 a.u., p < 0.001; Glu 0.5 µM 8216 ± 1103 a.u., p <
0.001; Glu 1 µM 12371 ± 461 a.u., p < 0.001).
FIGURE 3. (a) BzATP interferes with Amplex® Red Glutamic Acid/Glutamic
Oxidase Assay Kit. Granule neurons (14 days old) were stimulated for 1 min with
several concentrations of BzATP (100 nM-200 µM), in absence of magnesium, and
the medium was taken and the glutamate content was measured using Amplex®
Red Glutamic Acid/Glutamic Oxidase Assay Kit. As it can be observed in this
graph, BzATP induced an increase in resorufin fluorescence that was dose-
dependent. (b) Graph show that neither BzATP nor ATP stimulation induce pore
formation in granule neurons in culture. As positive control, granule neurons were
permeabilized with triton and an increase in YOPRO fluorescence could be
detected.
Data reported in this work confirm that BzATP interferes the
measurement of glutamate using Amplex® Red Glutamic Acid/
Glutamic Oxidase Assay Kit. Thus, the measurement of glutamate in
the media after stimulation with BzATP seems to indicate that P2X
induced pore formation through which glutamate reached
extracellular medium. However, the resorufin fluorescence was not
due to an increase in glutamate content but BzATP interfered on
Amplex Red oxidation catalyzed by HRP. These data are really
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interesting because demonstrate that resorufin fluorescence, in the
presence of BzATP, is not proportional to glutamate concentration
and, therefore, it must not be used as method to measure glutamate
concentration. This recommendation is applicable to the large variety
of assays that also used Amplex Red for quantitating specific
biological compounds (cholesterol, galactose, glucose, …) or enzymes
(monoamine oxidase, PLD, …).
FIGURE 4. Glutamate determination using Amplex® Red Glutamic Acid/
Glutamic Oxidase Assay Kit in absence or presence of BzATP. A working
solution containing 100 μM Amplex® Red reagent, 0.25 U/mL HRP, 0.08 U/mL
L-glutamate oxidase, 0.5 U/mL L-glutamate-pyruvate transaminase, and 200 μM
L-alanine was supplemented with different glutamate concentrations (0.1, 0.5 and
1 mM) alone or with BzATP (10 and 100 mM). After incubation at 37º C,
resorufin fluorescence was measured as indicated in methods section.
In that sense, in a recent report Kukley et al. (10) showed that
catabolism of BzATP, and subsequent adenosine A1 receptor
activation, depressed field potentials (fEPSP) at hippocampal
synapses. This conclusion was reached analysing BzATP hydrolysis
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by diphosphohydrolases and nucleotidases and measuring the
amount of inorganic phosphate released with amplex red based-Pi
Per Phosphate Assay Kit. However, they incubated together BzATP
and HRP to know the phosphate concentration. Thus, in agreement
with the results obtained in this work it could be possible that
resorfurin fluorescence resulted affected by BzATP and not
corresponded, therefore, completely to BzATP catabolism. Similarly,
Parvathenani et al. (11) studied the role played by P2X7 receptor in
superoxide production in primary microglia. Thus, superoxide (O–2)
was measured indirectly through the detection of hydrogen peroxide
(H2O2) by
 using an Amplex Red based assay. Thus, microglia cells
were stimulated with BzATP in a 96-well plate containing 0.2 units/
mL horseradish peroxidase and 50 µM Amplex Red. It is relevant to
indicate that Amplex Red and BzATP were incubated together.
Accordingly to the results reported in this work where HRP-mediated
Amplex Red oxidation, in presence of BzATP, is not proportional to
H2O2 formed, it seems logical to hypothesize that resorufin
fluorescence detected by Parvathenani and co-workers are not
completely due to superoxide production but BzATP-mediated
resorufin production could also be involved.
In summary, the measurement of glutamate concentration by
Amplex® Red Glutamic Acid/Glutamic Oxidase Assay Kit results
altered when BzATP is present in the medium. Thus, Amplex Red
oxidation catalyzed by HRP is significantly enhanced by BzATP, even
in absence of H2O2. Taking into account that Amplex Red oxidation
by HRP is a shared reaction in Amplex Red-based assays, extra
caution is needed to take when these assays are used with BzATP in
order to avoid misinterpretations of the results.
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